Levels of rubella antibody among vaccinated and unvaccinated Portuguese mothers and their newborns

Vaccine

Volumn 24, Issue 49-50, 2006, Pages 7142-7147

  Gonçalves, Guilherme ^a   Nascimento, Maria São José ^b   Réu, Cristina ^b   Cutts, Felicity T ^c  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Rubella IgG; Transplacental transport; Vaccination

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; RUBELLA VACCINE;

ADULT; ARTICLE; CORD SERUM; ETHNIC GROUP; FEMALE; FLUORESCENCE; HUMAN; IMMUNOASSAY; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MATERNAL SERUM; MOTHER; NEWBORN; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; RUBELLA; SENSITIVITY ANALYSIS; VACCINATION;

ADULT; AGE FACTORS; ANTIBODIES, VIRAL; EDUCATION; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; PARITY; PORTUGAL; PREGNANCY; RUBELLA; RUBELLA VACCINE; SEX FACTORS; VACCINATION;

EID: 33846200845     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.062     Document Type: Article

References (42)

1. Freitas M.G., Paixão M.T., and Branco M.J. Introdução. A vacinação em Portugal. PORTUGAL, Ministério da Saúde, Direcção-Geral da Saúde ed lit. Avaliação do programa nacional de vacinação e melhoria do seu custo-efectividade: 2° inquérito serológico nacional Portugal Continental 2001-2002 (2004), DGS, Lisboa p. 28-9
2. Robertson S.E., Cutts F.T., Samuel R., and Diaz-Ortega J.L. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella. Bull World Health Organ 75 1 (1997) 60-80
3. Plotkin SA, Reef S. Rubella vaccine. In: Plotkin S, Orenstein WA, editors. With assistance of Offit PA. Vaccines, 4th ed. Philadelphia, USA: Saunders, An Imprint of Elsevier; 2004 (Chapter 26).
4. Portugal. Ministério da Saúde. Direcção Geral dos Cuidados de Saúde Primários. Programa de vacinação contra a parotidite epidémica. Norma de Serviço No 5/DTP, 12/02/1987.
5. Portugal. Ministério da Saúde. Direcção Geral dos Cuidados de Saúde Primários. Normas de vacinação do programa national de vacinação. Circular Normativa No 10/DTF, 04/09/1990.
6. Portugal. Direcção-Geral da Saúde. Programa Nacional de Vacinação (Orientações Técnicas 10). Lisboa; 2001.
7. Cutts F.T., Robertson S.E., Diaz-Ortega J.L., and Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Bull World Health Organ 75 1 (1997) 55-68
8. Saldanha M.J., and Azevedo A. Rubéola congenital-ainda entre nós. Acta Med Port 8 5 (1995) 319-322
9. Sampayo F., and Pinto F.F. Distribuição por sexos das cardiopatias congénitas. Acta Med Port 7 (1994) 413-418
10. Feijó MJ. Centro de Estudos e Registo de Anomalias Congénitas. Relatório de 1997 a 1999. Observatório Nacional de Saúde. Instituto Nacional de Saúde Dr. Ricardo Jorge. Lisboa; 2003.
11. Gonçalves G., Frutuoso M.A., Ferreira M.C., and Freitas M.G. High vaccine coverage in the north of Portugal. A strategy to assess and increase coverage. Eurosurveillance 10 5 (2005) 98-102
12. Ayres L, Soares de Oliveira JM. Inquérito Serológico Nacional 1979/80. 11/Pesquisa de anticorpos anti-vírus da rubéola. Arquivos do Instituto Nacional de Saúde 1983;VIII:85-93.
13. Palminha P., Pité M.R., and Lopo S. Vírus da rubéola. PORTUGAL, Ministério da Saúde, Direcção-Geral da Saúde ed lit. Avaliação do programa nacional de vacinação e melhoria do seu custo-efectividade: 2° inquérito serológico nacional Portugal Continental 2001-2002 (2004), DGS, Lisboa p. 179-90
14. Oliveira J., Cunha S., Côrte-Real R., Sampaio L., Dias N., and Meliço-Silvestre A. Prevalência de anticorpos anti-sarampo, rubéola, papeira e varicela numa população de trabalhadores de saúde. Acta Med Port 8 (1995) 207-216
15. Oliveira J., Dias N., Ferreira T.M., da Cunha S., Costa D., Côrte-Real R., et al. Determinação da susceptibilidade ao sarampo, rubéola, papeira e varicela nos estudantes das áreas ligadas à saúde. Acta Med Port 12 (1999) 155-160
16. Pinheiro C.D., Santos M.A., Afonso S., Correia A.M., and Gonçalves G. Evidência serológica para fundamentar a definição de recomendações de vacinação de mulheres que se prostituem. Saúde em Números 15 4 (2000) 25-29
17. Furesz J. Antibody response of school children to live attenuated rubella virus vaccines as measured with various serologic methods. Am J Epidemiol 95 (1972) 536-541
18. Best J.M. Rubella vaccines: past, present and future. Epidemiol Infect 107 (1991) 17-30
19. Fitzpatrick S.B., Anthony R., and Heald F. Serological response to rubella revaccination in adolescent females. J Adolesc Health Care 4 (1983) 168-170
20. Pebody R.G., Gay N.J., Hesketh L.M., Vyse A., Morgan-Capner P., Brown D.W., et al. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine 20 (2002) 1134-1140
21. Kohler P.F., and Farr R.S. Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport. Nature 210 (1966) 1070-1071
22. Griffiths P.D., Berney S.I., Argent S., and Heath R.B. Antibody against viruses in maternal and cord sera: specific antibody is concentrated on the fetal side of the circulation. J Hyg (Lond) 89 2 (October) (1982) 303-310
23. Leineweber B., Grote V., Schaad U.B., and Heininger U. Transplacentaly acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J (2004)
24. Sato H., Albrecht P., Reynolds D.W., Stagno S., and Ennis F.A. Transfer of measles, mumps and rubella antibodies from mother to infant. Am J Dis Child 133 (1979) 1240-1243
25. Doroudchi M., Dehaghani A.S., Emad K., and Ghaderi A. Placental transfer of rubella-specific IgG in fullterm and preterm newborns. Int J Gyn Obst 81 (2003) 157-162
26. Gonçalves G., Nascimento M.S.J., and Barros H. Transmissão de imunidade passiva natural contra o sarampo, papeira e rubéola. Arq Med 10 Suppl. 4 (1996) 15-17
27. Weerasekera D.S., Fernandado S., and Weerasekera M.M. Susceptibility to rubella among pregnant women and the serological evidence of congenital rubella in newborn babies at Colombo South Teaching Hospital. Ceylon Med J 48 2 (2003) 51-53
28. Gonçalves G. Passive immunity against measles. PhD dissertation. London School of Hygiene and Tropical Medicine: University of London; 1996.
29. Skendzel L.P. Rubella immunity: defining the level of protective antibody. Am J Clin Pathol 106 (1996) 170-174
30. Matter L., Kogelschatz K., and Germann D. Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations. J Infect Dis 175 (1997) 749-755
31. Dean A.G., Dean J.A., Coulombier D., Brendel K.A., Smith D.C., Burton A.H., et al. Epi Info, version 6.04: a word processing, database and statistics program for epidemiology on microcomputers (2001), Centers for Disease Control and Prevention, Atlanta, GA, USA
32. StataCorp. Stata statistical software: release 7.0. College Station, TX: Stata Corporation; 2001.
33. Black F.L., Lamm S.H., Emmons J.E., and Pinheiro F.P. Reactions to rubella vaccine and persistence of antibody in virgin-soil populations after vaccination and wild-virus-induced immunization. J Infect Dis 133 (1976) 393-398
34. Bottiger M., and Heller L. Experiences from vaccination and revaccination of teenage girls with three different rubella vaccines. J Biol Stand 4 (1976) 107-114
35. Gonçalves G., Cutts F.T., Hills M., Rebelo-Andrade H., Trigo F.A., and Barros H. Transplacental transfer of measles and total IgG. Epidemiol Infect 122 (1999) 273-279
36. Brugha R., Ramsey M., Forsey T., and Brown D. A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women. Epidemiol Infect 117 3 (1996) 519-524
37. Gieβauf A., Letschka T., Walder G., Dierich M.P., and Wurzner R. A synthetic ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity. J Immun Meth 287 (2004) 1-11
38. Horstmann D.M., Liebhaber H., and Kohorn E.I. Post-partum vaccination of rubella susceptible women. Lancet 2 (1970) 1003-1006
39. Edmond E., and Zealley H. The impact of a rubella prevention policy on the outcome of rubella in pregnancy. Br J Obstet Gynaecol 93 (1986) 563-567
40. Sharp D.S., and Macdonald H. Use of medroxyprogesterone acetate as a contraceptive in conjunction with early postpartum rubella vaccination. Br Med J 4 (1973) 443-446
41. Greaves W.L., Orenstein W.A., Stetler H.C., Preblud S.R., Hinman R.A., and Bart K.J. Prevention of rubella transmission in medical facilities. JAMA 248 (1982) 861-864
42. Weber D.J., Rutala W.A., and Orenstein W.A. Prevention of mumps, measles, and rubella among hospital personnel. J Pediatr 119 (1991) 322-326